PL2863896T3 - Postać farmaceutyczna do uwalniania substancji czynnych - Google Patents
Postać farmaceutyczna do uwalniania substancji czynnychInfo
- Publication number
- PL2863896T3 PL2863896T3 PL13730597T PL13730597T PL2863896T3 PL 2863896 T3 PL2863896 T3 PL 2863896T3 PL 13730597 T PL13730597 T PL 13730597T PL 13730597 T PL13730597 T PL 13730597T PL 2863896 T3 PL2863896 T3 PL 2863896T3
- Authority
- PL
- Poland
- Prior art keywords
- dosageform
- liberation
- active agents
- agents
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012105528.9A DE102012105528A1 (de) | 2012-06-25 | 2012-06-25 | Arzneiform zur Freisetzung von Wirkstoffen |
EP13730597.5A EP2863896B1 (de) | 2012-06-25 | 2013-06-24 | Arzneiform zur freisetzung von wirkstoffen |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2863896T3 true PL2863896T3 (pl) | 2017-04-28 |
Family
ID=48656002
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13730597T PL2863896T3 (pl) | 2012-06-25 | 2013-06-24 | Postać farmaceutyczna do uwalniania substancji czynnych |
PL13173438T PL2679216T3 (pl) | 2012-06-25 | 2013-06-24 | Postać farmaceutyczna do zmodyfikowanego uwalniania betahistyny |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13173438T PL2679216T3 (pl) | 2012-06-25 | 2013-06-24 | Postać farmaceutyczna do zmodyfikowanego uwalniania betahistyny |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP2679216B1 (pl) |
AU (1) | AU2013283473B2 (pl) |
BR (1) | BR112014032578B1 (pl) |
CA (1) | CA2877190C (pl) |
CO (1) | CO7250447A2 (pl) |
DE (1) | DE102012105528A1 (pl) |
DK (1) | DK2679216T3 (pl) |
EA (1) | EA030871B1 (pl) |
ES (2) | ES2546172T3 (pl) |
HU (2) | HUE025739T2 (pl) |
IL (1) | IL236466B (pl) |
IN (1) | IN2014MN02526A (pl) |
MX (1) | MX367284B (pl) |
MY (1) | MY168531A (pl) |
PH (1) | PH12014502836A1 (pl) |
PL (2) | PL2863896T3 (pl) |
PT (2) | PT2679216E (pl) |
UA (1) | UA118836C2 (pl) |
WO (1) | WO2014001267A2 (pl) |
ZA (1) | ZA201409506B (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
PT3431078T (pt) | 2017-07-20 | 2021-04-21 | Intas Pharmaceuticals Ltd | Composições orais sólidas de libertação prolongada não pulsáteis de betaistina |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
DE102018129419A1 (de) | 2018-11-22 | 2020-05-28 | Johannes Gutenberg-Universität Mainz | Acrylat-Copolymer für galenische Anwendungen |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
IT1229237B (it) * | 1989-05-08 | 1991-07-26 | Prodotti Formenti | Sali di (2-(piridil)etil) metilammina |
ES2051658T3 (es) * | 1992-08-06 | 1998-06-16 | Gergely Gerhard | Comprimidos efervescentes faciles de administrar. |
HRP970493A2 (en) | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
US6419960B1 (en) * | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
IT1309591B1 (it) | 1999-03-05 | 2002-01-24 | Formenti Farmaceutici Spa | Composizioni a rilascio controllato di betaistina. |
DE10010509A1 (de) | 2000-03-08 | 2001-09-13 | Dresden Arzneimittel | Pharmazeutische Formulierungen |
DE10104880A1 (de) | 2001-01-31 | 2002-08-08 | Roehm Gmbh | Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen |
DE60320965D1 (de) * | 2003-07-04 | 2008-06-26 | Formenti Farmaceutici Spa | Betahistinezubereitungen mit kontrollierter Freisetzung |
US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
ES2393814T3 (es) * | 2007-04-04 | 2012-12-28 | Sigmoid Pharma Limited | Una composición farmacéutica oral |
US20130323309A1 (en) * | 2011-02-17 | 2013-12-05 | Lupin Limited | Sustained Release Composition of Memantine |
-
2012
- 2012-06-25 DE DE102012105528.9A patent/DE102012105528A1/de not_active Ceased
-
2013
- 2013-06-24 EP EP13173438.6A patent/EP2679216B1/de active Active
- 2013-06-24 ES ES13173438.6T patent/ES2546172T3/es active Active
- 2013-06-24 EA EA201500044A patent/EA030871B1/ru unknown
- 2013-06-24 PL PL13730597T patent/PL2863896T3/pl unknown
- 2013-06-24 MY MYPI2014003551A patent/MY168531A/en unknown
- 2013-06-24 UA UAA201500502A patent/UA118836C2/uk unknown
- 2013-06-24 MX MX2014015660A patent/MX367284B/es active IP Right Grant
- 2013-06-24 AU AU2013283473A patent/AU2013283473B2/en active Active
- 2013-06-24 BR BR112014032578-2A patent/BR112014032578B1/pt active IP Right Grant
- 2013-06-24 PT PT131734386T patent/PT2679216E/pt unknown
- 2013-06-24 ES ES13730597.5T patent/ES2607447T3/es active Active
- 2013-06-24 PT PT137305975T patent/PT2863896T/pt unknown
- 2013-06-24 PL PL13173438T patent/PL2679216T3/pl unknown
- 2013-06-24 CA CA2877190A patent/CA2877190C/en active Active
- 2013-06-24 EP EP13730597.5A patent/EP2863896B1/de active Active
- 2013-06-24 IN IN2526MUN2014 patent/IN2014MN02526A/en unknown
- 2013-06-24 DK DK13173438.6T patent/DK2679216T3/en active
- 2013-06-24 WO PCT/EP2013/063162 patent/WO2014001267A2/de active Application Filing
- 2013-06-24 HU HUE13173438A patent/HUE025739T2/en unknown
- 2013-06-24 HU HUE13730597A patent/HUE031246T2/en unknown
-
2014
- 2014-12-19 PH PH12014502836A patent/PH12014502836A1/en unknown
- 2014-12-23 ZA ZA2014/09506A patent/ZA201409506B/en unknown
- 2014-12-25 IL IL236466A patent/IL236466B/en active IP Right Grant
-
2015
- 2015-01-15 CO CO15007542A patent/CO7250447A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1203963A1 (en) | Novel therapeutic agents | |
TWI561171B (en) | Active compound combinations | |
EP2814472A4 (en) | DITHIOAMINE REDUCING AGENTS | |
GB201212513D0 (en) | Therapeutic agents | |
GB201216018D0 (en) | Pharmacologically active compounds | |
EP2823830A4 (en) | MESH-HIGHNESS MEDIUM | |
HK1207830A1 (en) | Dressing having the controlled release of active agents | |
HK1202859A1 (en) | Anti -malarial agents | |
IL239484A0 (en) | Materials for omitting enterprise-tumor cells | |
GB201217704D0 (en) | Therapeutic agents | |
LT2812013T (lt) | Kompozicija, skirta džs gydymui | |
ZA201408094B (en) | Anti-malarial agents | |
HK1205754A1 (en) | Agent for the surface epilamization of an article | |
PT2863896T (pt) | Forma farmacêutica para libertação de substâncias activas | |
PT2864328T (pt) | Compostos farmaceuticamente ativos | |
RS55201B1 (sr) | Antimalarijski agensi | |
ZA201405764B (en) | Novel therapeutic agents | |
GB201223021D0 (en) | Therapeutic agents | |
GB201214985D0 (en) | Modified therapeutic agents | |
GB201212512D0 (en) | Therapeutic agents | |
GB201213712D0 (en) | Modified therapeutic agents | |
GB201210233D0 (en) | Therapeutic agents |